• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody for Immunofluorescen

  2026-06-12

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enables researchers to achieve sensitive and specific detection of rabbit IgG in immunofluorescence, immunohistochemistry, and related assays. It is best suited for workflows requiring robust signal amplification and precise secondary antibody labeling. This reagent is not intended for diagnostic or medical applications and should not be used outside research settings.

• Hydroxycinnamic Acids Attenuate Inflammation via COPII–STING

  2026-06-12

  This study reveals that hydroxycinnamic acids (HCAs) such as cinnamic, caffeic, and ferulic acids directly target the Sec24 B-site of the COPII coat complex, inhibiting STING trafficking and downstream inflammatory signaling. These findings provide a mechanistic basis for the anti-inflammatory and metabolic effects of HCA-rich traditional Chinese medicines, with translational implications for metabolic and autoinflammatory disease management.

• Optimizing Mouse Genotyping: Science Behind Lysis Buffer Eff

  2026-06-11

  Explore how lysis buffer, a key rapid genotyping kit component, streamlines mouse genomic DNA extraction. This article dives deeper than standard protocols, revealing the scientific rationale for buffer optimization and its link to precision genetic research.

• ML-7 Hydrochloride: Novel Insights for Vascular Barrier Rese

  2026-06-11

  Discover how ML-7 hydrochloride, a selective myosin light chain kinase inhibitor, is transforming vascular endothelial dysfunction models and cytoskeletal research. This article uniquely bridges MLCK-mediated phosphorylation with advanced barrier and infection assays.

• Moxidectin (SKU B3611): Reliable Anthelmintic for Advanced A

  2026-06-10

  This article addresses experimental challenges in cell viability and antifungal synergy assays, highlighting the scientific advantages of Moxidectin (SKU B3611). Drawing on peer-reviewed data and practical protocols, it guides researchers in leveraging Moxidectin’s macrocyclic lactone properties for robust, reproducible results.

• Synergistic CDK4/6 and BET Inhibition Suppresses EMT in PDAC

  2026-06-10

  Gu et al. (2025) demonstrate that dual inhibition of CDK4/6 and BET proteins in pancreatic ductal adenocarcinoma (PDAC) provides synergistic suppression of tumor growth and epithelial-mesenchymal transition (EMT) by modulating the GSK3β-mediated Wnt/β-catenin pathway. These findings highlight the importance of pathway crosstalk in optimizing anti-metastatic strategies and suggest new avenues for preclinical intervention.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Use Guide

  2026-06-09

  Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive detection of rabbit IgG in immunofluorescence, IHC, and related workflows where direct evidence for its performance may be limited. It is suitable for research applications requiring a Cy3-conjugated secondary antibody but should not be used for diagnostic or clinical purposes.

• ECL Western Blotting Substrate: Technical Use and Parameters

  2026-06-09

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive HRP detection reagent designed for sensitive and clear protein visualization in Western blot assays. It addresses the need for reliable chemiluminescent detection in workflows focusing on molecular biology, cancer biology, and signal transduction pathway research. This substrate is not suitable for protocols requiring fluorescent or radioisotopic detection.

• AT-406 (SM-406): Strategic IAP Antagonism for Translational

  2026-06-08

  This thought-leadership article explores how mechanistic insight into inhibitor of apoptosis protein (IAP) antagonism, exemplified by the orally bioavailable agent AT-406 (SM-406), is transforming translational cancer research. By dissecting the molecular, experimental, and strategic considerations, we guide researchers seeking to leverage apoptosis pathway modulation for therapeutic innovation.

• Prostaglandin E2: Advanced Insights for Inflammation and Tis

  2026-06-08

  Explore the multifaceted biology of Prostaglandin E2 (PGE2) in inflammation research and microenvironmental modulation. This article delivers a deep scientific analysis highlighting recent innovations and novel assay strategies with PGE2.

• DMXAA (Vadimezan): Molecular Insights and Translational Impa

  2026-06-07

  Uncover the molecular mechanisms of DMXAA (Vadimezan) as a vascular disrupting agent and DT-diaphorase inhibitor in cancer biology research. This article uniquely explores advanced mechanistic insights, translational applications, and the relevance of recent breakthroughs for optimizing assay design.

• Phosphatase Inhibitor Cocktail: Precision in Phosphorylation

  2026-06-06

  Protecting labile phosphorylation states is critical for mechanistic studies in metabolism and signal transduction. APExBIO’s Phosphatase Inhibitor Cocktail (2 Tubes, 100X) excels in preserving these modifications during sample prep, enabling accurate kinase profiling and reproducible immunoblotting, even in challenging metabolic contexts.

• Acridine Orange hydrochloride: Practical Guide for Different

  2026-06-05

  Acridine Orange hydrochloride enables rapid, dual-fluorescence staining of DNA and RNA for cytochemical workflows such as cell cycle analysis and apoptosis detection, especially via flow cytofluorometry. This product is best suited for in situ nucleic acid discrimination where high purity, reproducibility, and quick solution use are critical. It is not recommended for applications outside validated nucleic acid staining protocols or for scenarios requiring long-term solution storage.

• Cell-Surface LAMP1 as a Senescence Marker in Aging and Fibro

  2026-06-05

  This study establishes cell-surface LAMP1 as a robust and selective biomarker of cellular senescence across aging and fibrotic lung pathology. By integrating transcriptomic profiling, antibody-drug conjugates, and in vivo models, it provides a critical foundation for improved detection and targeted elimination of senescent cells in age-related disease research.

• PXR Agonists Reverse Myocardial Injury in Adenine-Induced HF

  2026-06-04

  This study establishes a robust adenine-induced mouse model of heart failure with supranormal ejection fraction (HFsnEF) and demonstrates that PXR agonists can reverse myocardial apoptosis and pathological remodeling through modulation of the p53-Bax/Bcl2 pathway. These findings offer a mechanistic foundation for targeted HFsnEF research and inform the use of PXR agonists in translational cardiovascular studies.

16115 records 1/1075 page Next 12345 下5页 Last page